Immune-mediated diseases in primary sclerosing cholangitis

Digestive and Liver Disease

Volumn 43, Issue 10, 2011, Pages 802-806

  Lamberts, Laetitia E ^a   Janse, Marcel ^a   Haagsma, Elizabeth B ^a   van den Berg, Arie P ^a   Weersma, Rinse K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autoimmune disease; Cholestatic liver disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CROHN DISEASE; DEATH; ENTERITIS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SCHOOL CHILD; SURVIVAL; THYROID DISEASE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHILD; CHILD, PRESCHOOL; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; DIABETES MELLITUS, TYPE 1; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; INFLAMMATORY BOWEL DISEASES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SARCOIDOSIS; THYROID DISEASES; YOUNG ADULT;

EID: 80052460705     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.05.009     Document Type: Article

References (36)

1. Bambha K., Kim W.R., Talwalkar J., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125:1364-1369.
2. Boberg K.M., Aadland E., Jahnsen J., et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand. J. Gastroenterol. 1998, 33:99-103.
3. Broome U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610-615.
4. Farrant J.M., Hayllar K.M., Wilkinson M.L., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710-1717.
5. Tischendorf J.J., Hecker H., Kruger M., et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am. J. Gastroenterol. 2007, 102:107-114.
6. Talwalkar J.A., Lindor K.D. Primary sclerosing cholangitis. Inflamm. Bowel Dis. 2005, 11:62-72.
7. Angulo P., Peter J.B., Gershwin M.E., et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J. Hepatol. 2000, 32:182-187.
8. Bodenheimer H.C., LaRusso N.F., Thayer W.R., et al. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983, 3:150-154.
9. Boberg K.M., Fausa O., Haaland T., et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996, 23:1369-1376.
10. Ponsioen C.Y., Kuiper H., Ten Kate F.J., et al. Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. Eur. J. Gastroenterol. Hepatol. 1999, 11:769-774.
11. Schrumpf E., Fausa O., Forre O., et al. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand. J. Gastroenterol. 1982, 17:187-191.
12. Karlsen T.H., Franke A., Melum E., et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010, 138:1102-1111.
13. Bergquist A., Lindberg G., Saarinen S., Broome U. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J. Hepatol. 2005, 42:252-256.
14. Schrumpf E., Elgjo K., Fausa O., et al. Sclerosing cholangitis in ulcerative colitis. Scand. J. Gastroenterol. 1980, 15:689-697.
15. Olsson R., Danielsson A., Jarnerot G., et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991, 100:1319-1323.
16. Aadland E., Schrumpf E., Fausa O., et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand. J. Gastroenterol. 1987, 22:655-664.
17. Loftus E.V., Harewood G.C., Loftus C.G., et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005, 54:91-96.
18. Beuers U., Rust C. Overlap syndromes. Semin. Liver Dis. 2005, 25:311-320.
19. Rust C., Beuers U. Overlap syndromes among autoimmune liver diseases. World J. Gastroenterol. 2008, 14:3368-3373.
20. van Buuren H.R., van Hoogstraten H.J.E., Terkivatan T., et al. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J. Hepatol. 2000, 33:543-548.
21. Saarinen S., Olerup O., Broome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 2000, 95:3195-3199.
22. Chapman R.W., Arborgh B.A., Rhodes J.M., et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980, 21:870-877.
23. Evans J.G., Acheson E.D. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965, 6:311-324.
24. Farmer R.G., Hawk W.A., Turnbull R.B. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975, 68:627-635.
25. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
26. Van Steenbergen W., Fevery J., Vandenbrande P., et al. Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis, Report of a unique association. J. Clin. Gastroenterol. 1987, 9:574-579.
27. Ilan Y., Rappaport I., Feigin R., Ben-Chetrit E. Primary sclerosing cholangitis in sarcoidosis. J. Clin. Gastroenterol. 1993, 16:326-328.
28. Alam I., Levenson S.D., Ferrell L.D., Bass N.M. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig. Dis. Sci. 1997, 42:1295-1301.
29. Tombazzi C., Waters B., Ismail M.K., et al. Sarcoidosis mimicking primary sclerosing cholangitis requiring liver transplantation. Ann. Hepatol. 2008, 7:83-86.
30. Okolicsanyi L., Fabris L., Viaggi S., et al. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur. J. Gastroenterol. Hepatol. 1996, 8:685-691.
31. Somers E.C., Thomas S.L., Smeeth L., Hall A.J. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006, 17:202-217.
32. Fasano A. Systemic autoimmune disorders in celiac disease. Curr. Opin. Gastroenterol. 2006, 22:674-679.
33. Teufel A., Weinmann A., Kahaly G.J., et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J. Clin. Gastroenterol. 2010, 44:208-213.
34. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 2009, 10:43-55.
35. Cullen S.N., Chapman R.W. Review article: current management of primary sclerosing cholangitis. Aliment. Pharmacol. Ther. 2005, 21:933-948.
36. Hommes D.W., Erkelens W., Ponsioen C., et al. A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis. J. Clin. Gastroenterol. 2008, 42:522-526.